Authors:
Haddad, E
Paczesny, S
Leblond, V
Seigneurin, JM
Stern, M
Achkar, A
Bauwens, M
Delwail, V
Debray, D
Duvoux, C
Hubert, P
de Ligny, BH
Wijdenes, J
Durandy, A
Fischer, A
Citation: E. Haddad et al., Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trial, BLOOD, 97(6), 2001, pp. 1590-1597
Authors:
Milpied, N
Vasseur, B
Parquet, N
Garnier, JL
Antoine, C
Quartier, P
Carret, AS
Bouscary, D
Faye, A
Bourbigot, B
Reguerre, Y
Stoppa, AM
Bourquard, P
de Ligny, BH
Dubief, F
Mathieu-Boue, A
Leblond, V
Citation: N. Milpied et al., Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients, ANN ONCOL, 11, 2000, pp. 113-116
Authors:
de Ligny, BH
Etienne, I
Francois, A
Toupance, O
Buchler, M
Touchard, G
Lepogamp, P
Comoz, F
Lobbedez, T
Godin, M
Ryckelynck, JP
Lebranchu, Y
Citation: Bh. De Ligny et al., Polyomavirus-induced acute tubulo-interstitial nephritis in renal allograft recipients, TRANSPLAN P, 32(8), 2000, pp. 2760-2761
Authors:
Touchard, G
de Ligny, BH
Griveau, AM
Pujo, M
Jollet, I
Lobbedez, T
Bauwens, M
Bridoux, F
Alcalay, D
Citation: G. Touchard et al., Comparative results of a randomized transfusion of HLA-5,-6 mismatched (one unit) versus HLA semi-identical (one unit) blood in first renal allograftrecipients, TRANSPLAN P, 32(8), 2000, pp. 2771-2772
Citation: Bh. De Ligny et Y. Lebranchu, The use of thymoglobuline induction in renal transplantation: A pharmacovigilance study, TRANSPLAN P, 32(2), 2000, pp. 351-352